Cellectis (CLLS) Cost of Revenue (2015 - 2023)

Cellectis' Cost of Revenue history runs 9 years deep, the most recent figure standing at $167000.0 for Q4 2023.

• In Q4 2023, Cost of Revenue fell 75.8% year-over-year to $167000.0; the TTM figure through Dec 2023 stood at $737000.0 (down 58.39% YoY), while the FY2023 annual figure was $737000.0, down 58.41% from the prior year.
• Cost of Revenue was $167000.0 for Q4 2023 at Cellectis, down from $181000.0 in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $18.6 million in Q4 2020 to a low of $55000.0 in Q2 2023.
• Historically, Cost of Revenue has averaged $4.0 million across 5 years, with a median of $752500.0 in 2019.
• The sharpest annual moves came in 2019 and 2021: Cost of Revenue surged 685.0% in 2019, then slumped 98.7% in 2021.
• A 5-year view of Cost of Revenue shows it stood at $5.7 million in 2019, then jumped by 229.87% to $18.6 million in 2020, then plunged by 98.7% to $243000.0 in 2021, then jumped by 183.95% to $690000.0 in 2022, then slumped by 75.8% to $167000.0 in 2023.
• The last three Cost of Revenue figures came in at $167000.0 (Q4 2023), $181000.0 (Q3 2023), and $55000.0 (Q2 2023), per Business Quant data.